Table 1.
Potential prognostic miRNAs for ovarian cancer
| Tumor histology (n) | miRNA | Endpoint | Prognosis | Reference |
|---|---|---|---|---|
| EOC (48), PPC (7) | miR-200a, miR-200b, miR-429 | Overall survival | Good | [25], 2009 |
| SAC (185) | miR-410, miR-645 | Overall survival | Good | [26], 2011 |
| EOC (98) | miR-100 | Overall survival | Good | [27], 2012 |
| EOC (176) | miR-187 | Overall survival, recurrence-free survival | Good | [28], 2012 |
| EOC (100) | miR-150 | Overall survival, progression-free survival | Good | [29], 2014 |
| EOC (36) | miR-335 | Overall survival, recurrence-free survival | Good | [30], 2014 |
| EOC (146) | miR-196a | Overall survival, recurrence-free survival | Poor | [31], 2015 |
| EOC (211) | let-7a | Overall survival | Good | [32], 2015 |
SAC: Serous adenocarcinoma; EAC: Endometrioid adenocarcinoma; miRNAs: MicroRNAs; PPC: Primary peritoneal carcinomas.